In suspected MEN1 presenting with gastrinoma, which measurements should be followed regularly?

In suspected MEN1 presenting with gastrinoma, which measurements should be followed regularly?

• A. Serum calcium and PTH
• B. Serum calcium, PTH, and pituitary hormones
• C. Serum CK
• D. Serum gastrin

Answer: (B)

In MEN1, the two most common and clinically important sites to monitor are the parathyroids and the pituitary. Regularly checking serum calcium and PTH tracks parathyroid hyperplasia or adenomas, which are frequent in MEN1 and can drive hypercalcemia and other symptoms. Monitoring pituitary function with key pituitary hormones helps detect pituitary adenomas early, guiding management. While gastrinomas are part of MEN1, routine surveillance isn’t based solely on gastrin levels; they’re used if a gastrinoma is known or suspected, but don’t cover the parathyroid and pituitary disease that also demand ongoing follow-up. Therefore, the appropriate regular measurements are serum calcium, PTH, and pituitary hormones.

In MEN1, the two most common and clinically important sites to monitor are the parathyroids and the pituitary. Regularly checking serum calcium and PTH tracks parathyroid hyperplasia or adenomas, which are frequent in MEN1 and can drive hypercalcemia and other symptoms. Monitoring pituitary function with key pituitary hormones helps detect pituitary adenomas early, guiding management. While gastrinomas are part of MEN1, routine surveillance isn’t based solely on gastrin levels; they’re used if a gastrinoma is known or suspected, but don’t cover the parathyroid and pituitary disease that also demand ongoing follow-up. Therefore, the appropriate regular measurements are serum calcium, PTH, and pituitary hormones.